Sökresultat - Shu‐Ching Chang
- Visas 1 - 6 av 6 resultat
-
1
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma av Brendan D. Curti, Marka R. Crittenden, Steven K. Seung, Christopher Fountain, Roxanne Payne, Shu‐Ching Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick, Walter J. Urba
Publicerad 2020Artigo -
2
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer av Katherine Sanchez, Isaac Kim, Brie Chun, Joanna Pucilowska, William L. Redmond, Walter J. Urba, Maritza Martel, Yaping Wu, Mary Campbell, Zhaoyu Sun, Gary L. Grunkemeier, Shu‐Ching Chang, Brady Bernard, David B. Page
Publicerad 2021Artigo -
3
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells av Rebekka Duhen, Carmen Ballesteros‐Merino, Alexandra K. Frye, Eric Tran, Venkatesh Rajamanickam, Shu‐Ching Chang, Yoshinobu Koguchi, Carlo Bifulco, Brady Bernard, Rom S. Leidner, Brendan D. Curti, Bernard A. Fox, Walter J. Urba, R. Bryan Bell, Andrew D. Weinberg
Publicerad 2021Artigo -
4
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors av Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F.C.C. de Miranda, Cheri P. Goodall, Tiffany C. Blair, Bernard A. Fox, Jason McDermott, Shu‐Ching Chang, Gary L. Grunkemeier, Rom S. Leidner, R. Bryan Bell, Andrew D. Weinberg
Publicerad 2018Artigo -
5
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor av Brendan D. Curti, Yoshinobu Koguchi, Rom S. Leidner, Annah S. Rolig, Elizabeth R. Sturgill, Zhaoyu Sun, Yaping Wu, Venkatesh Rajamanickam, Brady Bernard, Ian Hilgart-Martiszus, Christopher Fountain, George Morris, Noriko Iwamoto, Takashi Shimada, Shu‐Ching Chang, Peter G. Traber, Eliezer Zomer, Jessie Horton, Harold Shlevin, William L. Redmond
Publicerad 2021Artigo -
6
Remdesivir and Mortality in Patients With Coronavirus Disease 2019 av George A. Diaz, Alyssa Christensen, Tobias Pusch, Delaney Goulet, Shu‐Ching Chang, Gary L. Grunkemeier, Paul A. McKelvey, Ari Robicsek, Tom French, Guilford Parsons, Glenn Doherty, Charles Laurenson, Ryan Roper, Jennifer Hadlock, Cameron Cover, Brent Footer, Philip A. Robinson, Mary Micikas, Jennifer Marfori, Charlotte Cronenweth, Yogavedya Mukkamala, Jamie Mackiewicz, Ekra Rai, Martha Dickinson Matson, Jodie Davila, Justin Rueda, Reda Tipton, Heather A. Algren, Brittney C Ward, Stephen P. Malkoski, Tyler J Gluckman, Gregory B Tallman, Henry Arguinchona, Terese Hammond, Steven Standaert, Joshua Christensen, Jose F. Echaiz, Robert Y. Choi, Daniel McClung, Albert D. Pacifico, Martin Fee, Farjad Sarafian, William R. Berrington, Jason D. Goldman
Publicerad 2021Artigo
Sökverktyg:
Relaterade ämnen
Medicine
Cancer research
Internal medicine
Immunology
Cancer
Immune system
Oncology
Antigen
Biology
Breast cancer
CD8
Head and neck cancer
Head and neck squamous-cell carcinoma
Immunotherapy
Melanoma
Pathology
Radiation therapy
Tumor-infiltrating lymphocytes
Adoptive cell transfer
Antibody
Basal cell
Biochemistry
Bioinformatics
Cancer immunotherapy
Clinical trial
Cohort
Cohort study
Confidence interval
Context (archaeology)
Coronavirus disease 2019 (COVID-19)